Cargando…

Corrigendum: Impact of Hydroxychloroquine on Antibody Responses to the SARS-CoV-2 Coronavirus

Detalles Bibliográficos
Autores principales:	Santos, Isabel Kinney Ferreira De Miranda, Costa, Carlos Henrique Nery
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667991/ https://www.ncbi.nlm.nih.gov/pubmed/33224154 http://dx.doi.org/10.3389/fimmu.2020.615628

Ejemplares similares

Impact of Hydroxychloroquine on Antibody Responses to the SARS-CoV-2 Coronavirus
por: de Miranda Santos, Isabel Kinney Ferreira, et al.
Publicado: (2020)

Impact of Treatment Regimens on Antibody Response to the SARS-CoV-2 Coronavirus
por: Shang, Yufeng, et al.
Publicado: (2021)

The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
por: Zhang, Yun-yu, et al.
Publicado: (2020)

The IgG glycome of SARS-CoV-2 infected individuals reflects disease course and severity
por: Siekman, Sterre L., et al.
Publicado: (2022)

Nanobodies: Prospects of Expanding the Gamut of Neutralizing Antibodies Against the Novel Coronavirus, SARS-CoV-2
por: Konwarh, Rocktotpal
Publicado: (2020)

Mapping monoclonal anti-SARS-CoV-2 antibody repertoires against diverse coronavirus antigens
por: de Souza, Matheus Oliveira, et al.
Publicado: (2022)

Persistence of SARS-CoV-2 Antibodies in Vaccinated Health Care Workers Analyzed by Coronavirus Antigen Microarray
por: Hosseinian, Sina, et al.
Publicado: (2022)

Immunodominant antibody responses directed to SARS-CoV-2 hotspot mutation sites and risk of immune escape
por: Oliveira, Jamille Ramos, et al.
Publicado: (2023)

Detection of anti-SARS-CoV-2 salivary antibodies in vaccinated adults
por: Castro, Vitória Tavares, et al.
Publicado: (2023)

Functional Analysis of Human and Feline Coronavirus Cross-Reactive Antibodies Directed Against the SARS-CoV-2 Fusion Peptide
por: Vanderheijden, Nathalie, et al.
Publicado: (2022)

Novel Monoclonal Antibodies and Recombined Antibodies Against Variant SARS-CoV-2
por: Xie, Jiajia, et al.
Publicado: (2021)

Potential Challenges for Coronavirus (SARS-CoV-2) Vaccines Under Trial
por: Usmani, Salman Sadullah, et al.
Publicado: (2020)

SARS-CoV-2-Seronegative Subjects Target CTL Epitopes in the SARS-CoV-2 Nucleoprotein Cross-Reactive to Common Cold Coronaviruses
por: Schmidt, Katja G., et al.
Publicado: (2021)

Hydroxychloroquine as Prophylaxis for Coronavirus SARS-CoV-2 Infection: Review of the Ongoing Clinical Trials
por: Galvis, Virgilio, et al.
Publicado: (2020)

Hydroxychloroquine as Prophylaxis for Coronavirus SARS-CoV-2 Infection: Review of the Ongoing Clinical Trials
por: Galvis, Virgilio, et al.
Publicado: (2020)

Detection of SARS-CoV-2 Specific Antibodies in Saliva Samples
por: Yu, Siyang, et al.
Publicado: (2022)

Long-Term Kinetics of SARS-CoV-2 Antibodies and Impact of Inactivated Vaccine on SARS-CoV-2 Antibodies Based on a COVID-19 Patients Cohort
por: Zhang, Shihan, et al.
Publicado: (2022)

Anti-SARS-CoV-2 Antibodies Within IVIg Preparations: Cross-Reactivities With Seasonal Coronaviruses, Natural Autoimmunity, and Therapeutic Implications
por: Dalakas, Marinos C., et al.
Publicado: (2021)

Hyperglycémie, hydroxychloroquine et SARS-CoV-2
por: Ilias, Ioannis, et al.
Publicado: (2021)

Boosting of cross-reactive antibodies to endemic coronaviruses by SARS-CoV-2 infection but not vaccination with stabilized spike
por: Crowley, Andrew R, et al.
Publicado: (2022)

Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies
por: Ricke, Darrell O.
Publicado: (2021)

The Mucosal and Serological Immune Responses to the Novel Coronavirus (SARS-CoV-2) Vaccines
por: Chan, Renee W. Y., et al.
Publicado: (2021)

Hexamerization of Anti-SARS CoV IgG1 Antibodies Improves Neutralization Capacity
por: Pande, Kalyan, et al.
Publicado: (2022)

Broadly-Neutralizing Antibodies Against Emerging SARS-CoV-2 Variants
por: Shrestha, Lok Bahadur, et al.
Publicado: (2021)

SARS-CoV-2 Antibodies Mediate Complement and Cellular Driven Inflammation
por: Jarlhelt, Ida, et al.
Publicado: (2021)

Evolving understanding of antibody-dependent enhancement (ADE) of SARS-CoV-2
por: Yang, Yalong, et al.
Publicado: (2022)

Antibodies to SARS-CoV-2 in follicular fluids and their association with assisted reproduction
por: Chillon, Thilo Samson, et al.
Publicado: (2023)

Corrigendum: Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits
por: Kim, Sung-Hee, et al.
Publicado: (2022)

Serum IgG anti-SARS-CoV-2 Binding Antibody Level Is Strongly Associated With IgA and Functional Antibody Levels in Adults Infected With SARS-CoV-2
por: Ye, Xunyan, et al.
Publicado: (2021)

Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses
por: Abdelrahman, Zeinab, et al.
Publicado: (2020)

Antibody Mediated Immunity to SARS-CoV-2 and Human Coronaviruses: Multiplex Beads Assay and Volumetric Absorptive Microsampling to Generate Immune Repertoire Cartography
por: Wang, Jiong, et al.
Publicado: (2021)

Milk From Women Diagnosed With COVID-19 Does Not Contain SARS-CoV-2 RNA but Has Persistent Levels of SARS-CoV-2-Specific IgA Antibodies
por: Pace, Ryan M., et al.
Publicado: (2021)

Saliva is suitable for SARS-CoV-2 antibodies detection after vaccination: A rapid systematic review
por: Guerra, Eliete Neves Silva, et al.
Publicado: (2022)

Corrigendum: The impact of circadian rhythm on Bacillus Calmette-Guérin vaccination effects on SARS-CoV-2 infections
por: Föhse, Konstantin, et al.
Publicado: (2023)

Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 Variants of Concern
por: Favorskaya, Irina A., et al.
Publicado: (2022)

Reaction of SARS-CoV-2 antibodies with other pathogens, vaccines, and food antigens
por: Vojdani, Aristo, et al.
Publicado: (2022)

Cellular immune response to SARS-CoV-2 in patients with primary antibody deficiencies
por: Mizera, Dorota, et al.
Publicado: (2023)

Frequent Infection of Cats With SARS-CoV-2 Irrespective of Pre-Existing Enzootic Coronavirus Immunity, Brazil 2020
por: de Oliveira-Filho, Edmilson F., et al.
Publicado: (2022)

Are higher antibody levels against seasonal human coronaviruses associated with a more robust humoral immune response after SARS-CoV-2 vaccination?
por: Asamoah-Boaheng, Michael, et al.
Publicado: (2022)

Pre-existing humoral immunity to low pathogenic human coronaviruses exhibits limited cross-reactive antibodies response against SARS-CoV-2 in children
por: Li, Nina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0vm3mjp7cqk7ra77etufilln32